Market revenue in 2021 | USD 206.6 million |
Market revenue in 2028 | USD 215.0 million |
Growth rate | 0.6% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Nucleic Acid Sequence Based Amplification (NASBA) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.66% in 2021. Horizon Databook has segmented the Mexico gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Being a developing economy, Mexico witnessed a number of challenges in implementing novel life science technologies in healthcare. These challenges include inadequate nutrition, limited resources, and lack of robust research network.
To amend this situation, several initiatives have commenced in the country that focus on detailed study of genetic makeup. In contrast, this scenario is set to change with the initiative of research studies on polymorphisms associated with common diseases in the country, thus providing a platform for creation of National Institute of Genomic Medicine (INMEGEN).
With the emerging biopharmaceutical industry in the country, the adoption of gene delivery technologies in the pharmaceutical industry is anticipated to witness lucrative growth in the coming years. Mexico is the second-largest pharmaceutical market in the Latin America region having significant growth potential.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into Mexico gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account